Quest DiagnosticsDGXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Revenue
$2.4B
Gross Profit
$804.0M
Operating Profit
$355.0M
Net Profit
$229.0M
Gross Margin
33.5%
Operating Margin
14.8%
Net Margin
9.6%
YoY Growth
2.5%
EPS
$2.03
Financial Flow
Quest Diagnostics Q2 2024 Financial Summary
Quest Diagnostics reported revenue of $2.4B for Q2 2024, with a net profit of $229.0M (9.6% margin). Cost of goods sold was $1.6B, operating expenses totaled $449.0M.
Key Financial Metrics
| Total Revenue | $2.4B |
|---|---|
| Net Profit | $229.0M |
| Gross Margin | 33.5% |
| Operating Margin | 14.8% |
| Report Period | Q2 2024 |
Quest Diagnostics Annual Revenue by Year
Quest Diagnostics annual revenue history includes year-by-year totals (for example, 2024 revenue was $9.9B).
| Year | Annual Revenue |
|---|---|
| 2024 | $9.9B |
| 2023 | $9.3B |
| 2022 | $9.9B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.29B | $2.37B | $2.40B | $2.49B | $2.62B | $2.65B | $2.76B | $2.82B |
| YoY Growth | -1.9% | 1.5% | 2.5% | 8.4% | 14.6% | 12.1% | 15.2% | 13.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.02B | $13.95B | $13.88B | $16.09B | $16.15B | $15.80B | $15.97B | $16.20B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $6.31B | $6.43B | $6.62B | $6.81B | $6.78B | $6.93B | $7.23B | $7.26B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $527.0M | $154.0M | $360.0M | $356.0M | $464.0M | $314.0M | $544.0M | $563.0M |
Other Health Care Companies
CI
Cigna
Revenue
$69.7B
Net Profit
N/A
CVS
CVS Health
Revenue
$105.7B
Net Profit
$2.9B
DVA
DaVita
Revenue
$3.6B
Net Profit
$234.2M
LH
Labcorp
Revenue
$3.6B
Net Profit
$261.1M
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B